
T4128 Human Primary Dermal Lymphatic Endothelial Cells express vWF and CD31, max 2 passages at 1:2, media change every 3 days, for human dermal lymphangiogenesis, lymphedema, tumor metastasis, and skin immune surveillance research. Supplied by ABM as 5×105 cells/1.0 ml, frozen; BSL-2; RUO. MTA required.